DE69232962D1 - Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält - Google Patents

Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält

Info

Publication number
DE69232962D1
DE69232962D1 DE69232962T DE69232962T DE69232962D1 DE 69232962 D1 DE69232962 D1 DE 69232962D1 DE 69232962 T DE69232962 T DE 69232962T DE 69232962 T DE69232962 T DE 69232962T DE 69232962 D1 DE69232962 D1 DE 69232962D1
Authority
DE
Germany
Prior art keywords
influence
vaccine
additive
sinergistic
inner body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69232962T
Other languages
English (en)
Other versions
DE69232962T2 (de
DE69232962T3 (de
Inventor
Catherine Moste-Deshairs
Bernard Meignier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9409015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69232962(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pasteur SA filed Critical Aventis Pasteur SA
Application granted granted Critical
Publication of DE69232962D1 publication Critical patent/DE69232962D1/de
Publication of DE69232962T2 publication Critical patent/DE69232962T2/de
Publication of DE69232962T3 publication Critical patent/DE69232962T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69232962T 1991-01-24 1992-01-24 Influenzaimpfstoff der als synergistisches zusatzmittel influenzavirus-innenkörper enthält Expired - Lifetime DE69232962T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9100806 1991-01-24
FR9100806A FR2671974A1 (fr) 1991-01-24 1991-01-24 Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.
PCT/FR1992/000066 WO1992013002A1 (fr) 1991-01-24 1992-01-24 Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal

Publications (3)

Publication Number Publication Date
DE69232962D1 true DE69232962D1 (de) 2003-04-24
DE69232962T2 DE69232962T2 (de) 2005-06-23
DE69232962T3 DE69232962T3 (de) 2007-11-08

Family

ID=9409015

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232962T Expired - Lifetime DE69232962T3 (de) 1991-01-24 1992-01-24 Influenzaimpfstoff der als synergistisches zusatzmittel influenzavirus-innenkörper enthält

Country Status (10)

Country Link
EP (1) EP0522138B2 (de)
AT (1) ATE234861T1 (de)
AU (1) AU654699B2 (de)
CA (1) CA2078985C (de)
DE (1) DE69232962T3 (de)
FR (1) FR2671974A1 (de)
IL (1) IL100765A (de)
NZ (1) NZ241398A (de)
WO (1) WO1992013002A1 (de)
ZA (1) ZA92510B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2156525A1 (en) * 1993-02-19 1994-09-01 Susan Dillon Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
WO1998046262A1 (en) * 1997-04-16 1998-10-22 Connaught Laboratories, Inc. Anti-influenza compositions supplemented with neuraminidase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
GB8502096D0 (en) * 1985-01-28 1985-02-27 Medical Res Council Influenza vaccine
US5136019A (en) * 1989-05-24 1992-08-04 Sri International Synthetic peptides for diagnosis and prevention of influenza virus infection and their use

Also Published As

Publication number Publication date
AU654699B2 (en) 1994-11-17
EP0522138B2 (de) 2007-02-14
CA2078985A1 (fr) 1992-07-25
DE69232962T2 (de) 2005-06-23
FR2671974B1 (de) 1995-03-03
NZ241398A (en) 1994-08-26
ATE234861T1 (de) 2003-04-15
IL100765A (en) 1996-06-18
DE69232962T3 (de) 2007-11-08
EP0522138A1 (de) 1993-01-13
WO1992013002A1 (fr) 1992-08-06
IL100765A0 (en) 1992-09-06
ZA92510B (en) 1992-11-25
FR2671974A1 (fr) 1992-07-31
AU1248792A (en) 1992-08-27
CA2078985C (fr) 2004-11-09
EP0522138B1 (de) 2003-03-19

Similar Documents

Publication Publication Date Title
DK0791571T3 (da) Benzoylderivater
BR8707672A (pt) Pirazolinas inseticidas
ES2124479T3 (es) Composiciones biocidas.
BR9205818A (pt) Composições azeotrópicas de 1,1,2,2-tetrafluororetano e semelhantes.
NO905438D0 (no) Virusmiddel.
DE69202822D1 (de) Silikonmodifizierte wässrige Überzugszusammensetzung.
NO900612L (no) Preservativ for vandige sammensetninger.
MX24890A (es) Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene.
TR26619A (tr) YENI BILESIKLER,BUNLARIN HAZIRLANMALARINA YÖNELIK ISLEMLER,BUNLARI ICEREN BILESIMLER VE BUNLARIN ZARARLI OT ÖLDüRüCüSü(HERBISIDAL) OLARAK KULLANI- MI.
IT1240773B (it) Perfezionamento composizioni pozzolaniche.
DE69003075D1 (de) Stabilisierungszusammensetzungen.
NO903474L (no) Fremgangsmaate for fremstilling av neoalkyltrioltriestere.
DE69232962D1 (de) Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält
DE68910676D1 (de) Verwendung von Creosot als antispastischer Wirkstoff.
DE59208398D1 (de) Neue synthetische Isohirudine mit verbesserter Stabilität
SE7811491L (sv) Ny polysackarid, forfarande for framstellning derav samt hypokolesterolkomposition innehallande den nya foreningen
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
DE69208681D1 (de) Verwendungen von 1,1,1,3,3,3-hexafluoropropan
DE69006508D1 (de) Azeotropähnliche zusammensetzungen von 1,3-dichlor-1,1,2,2,3-pentafluorpropan und 2-methyl-2-propanol.
SE8205110L (sv) Herdbar komposition och anvendning derav
NO900635D0 (no) Herderblanding, samt anvendelse av den.
ITRM910385A0 (it) Vaccini utilizzanti eritrociti come veicoli di antigeni.
DK316188D0 (da) Sulfolipopolysaccharider som stimolatorer for den ikke specifikke forsvarsmekanisme
NO900219D0 (no) Dihydroksybenzofenon-oksim, samt fremgangsmaate for fremstilling av slike oksimer.
DE69019610D1 (de) Cyclische Derivate des Amidinylthiocarbapenems.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: SAMOFI PASTEUR, LYON, FR

8327 Change in the person/name/address of the patent owner

Owner name: SANOFI PASTEUR, LYON, FR